Molecular analysis of IDH1/2 mutations and MGMT promoter methylation in gliomas and meningiomas

被引:0
|
作者
Saetta, A. [1 ]
Gioti, A. [1 ]
Chatziandreou, I. [1 ]
Tsioli, P. [1 ]
Soldatos, R. F. [1 ]
Sakellariou, S. [1 ]
Samaras, V. [1 ]
Sepsa, A. [1 ]
Zisakis, A. [1 ]
Korkolopoulou, P. [1 ]
Patsouris, E. [1 ]
机构
[1] Univ Athens, Dept Pathol 1, GR-10679 Athens, Greece
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:319 / 319
页数:1
相关论文
共 50 条
  • [41] MGMT Methylation is Strongly Associated with and May Precede IDH1/IDH2 Mutations in Adult Astrocytic and Oligodendroglial Tumours
    Mulholland, S. A.
    Malley, D. S.
    Hamoudi, R.
    Kocialkowski, S.
    Pearson, D.
    Collins, V. P.
    Ichimura, K.
    JOURNAL OF PATHOLOGY, 2011, 224 : S13 - S13
  • [42] IDH1 MUTATIONS, EGFR GENE AMPLIFICATION AND MGMT GENE PROMOTER METHYLATION IN GLIOSARCOMAS: SERIES OF 31 CASES WITH CLINCOPATHOLOGICAL FEATURES
    Epari, Sridhar
    Ahmed, Sharique
    Gurav, Mamta
    Raikar, Swati
    Moiyadi, Aliasgar
    Shetty, Prakash
    Gupta, Tejpal
    Jalali, Rakesh
    NEURO-ONCOLOGY, 2013, 15 : 157 - 157
  • [43] MGMT Promoter Methylation and IDH1 Mutations Do Not Affect [18F]FDOPA Uptake in Primary Brain Tumors
    Cimini, Andrea
    Chiaravalloti, Agostino
    Ricci, Maria
    Villani, Veronica
    Vanni, Gianluca
    Schillaci, Orazio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 9
  • [44] Detection of IDH1 and TERT promoter mutations with droplet digital PCR in diffuse gliomas
    Ge, Jia
    Liu, Michael Y.
    Li, Lei
    Deng, Qing
    Liu, Feng
    Luo, Ying
    Wang, Lihong
    Yao, Guangyin
    Zhu, Dandan
    Lu, Huimin
    Liang, Mei
    Deng, Song
    Zhou, Rong
    Luo, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (02): : 230 - +
  • [45] The correlation analysis of TERT promoter mutations with IDH1/2 mutations and 1p/19q detected in human gliomas
    Xu, Jie
    Xu, Fang-Ping
    Liu, Zhi-Hua
    Cui, Qian
    Zhang, Ke-Ping
    Li, Zhi
    MEDICINE, 2022, 101 (29) : E29668
  • [46] The value of promoter methylation of the MGMT gene and IDH mutations in secondary glioblastomas
    Bie, Li
    Li, Qian Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] MGMT METHYLATION, BRAF AND IDH1/2 MUTATIONS AND EGFR VARIANT III DETECTION AND THEIR ASSOCIATION WITH BEVACIZUMAB TREATMENT
    Rigakos, Georgios
    Spyri, Olympia
    Nomikos, Pau
    Stavridi, Flora
    Grossi, Irene
    Theodorakopoulou, Ioanna
    Assi, Avraam
    Kouvatseas, Georgios
    Papadopoulou, Eirini
    Nasioulas, Georgios
    Labropoulos, Stefanos
    Razis, Evangelia
    NEURO-ONCOLOGY, 2013, 15 : 72 - 72
  • [48] Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas
    Kim, Hyun Sik
    Kwon, Mi Jung
    Song, Joon Ho
    Kim, Eun Soo
    Kim, Ho Young
    Min, Kyueng-Whan
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (06) : 881 - 888
  • [49] Frequency and Association of IDH 1/2 Mutations with 1p19q LOH MGMT Promoter Methylation and EGFRvIII Mutations Among Different Types and Grades of Gliomas
    Cankovic, M.
    Whiteley, L.
    Chitale, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 900 - 900
  • [50] Autophagy and oxidative stress in gliomas with IDH1 mutations
    Misty R. Gilbert
    Yinxing Liu
    Janna Neltner
    Hong Pu
    Andrew Morris
    Manjula Sunkara
    Thomas Pittman
    Natasha Kyprianou
    Craig Horbinski
    Acta Neuropathologica, 2014, 127 : 221 - 233